Benefit-Risk Assessment of Leflunomide: An Appraisal of Leflunomide in Rheumatoid Arthritis 10 Years After Licensing

By Alcorn Nicola   Saunders Sarah   Madhok Rajan  

Drug Safety, Vol. 32, Iss. 12, 2009-12 ,pp. : 1123-1134

Adis International

Access to resources Recommend Favorite

Benefit-Risk Assessment of Bevacizumab in the Treatment of Breast Cancer

By Dienstmann Rodrigo  

Drug Safety, Vol. 35, Iss. 1, 2012-01 ,pp. : 15-25

Adis International

Access to resources Recommend Favorite

Benefit-Risk Assessment of Levetiracetam in the Treatment of Partial Seizures

By Abou-Khalil Bassel  

Drug Safety, Vol. 28, Iss. 10, 2005-01 ,pp. : 871-890

Adis International

Access to resources Recommend Favorite

Benefit-Risk Assessment of Rofecoxib in the Treatment of Osteoarthritis

By Schmidt H.   Woodcock B.G.   Geisslinger G.  

Drug Safety, Vol. 27, Iss. 3, 2004-01 ,pp. : 185-196

Adis International

Access to resources Recommend Favorite

A Benefit-Risk Assessment of Dapoxetine in the Treatment of Premature Ejaculation

By Hutchinson Kate   Cruickshank Kelly   Wylie Kevan  

Drug Safety, Vol. 35, Iss. 5, 2012-05 ,pp. : 359-372

Adis International

Access to resources Recommend Favorite